Dr. Eugene Muchnik, MD

Dr. Muchnik practices at UPMC Williamsport in Williamsport, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Muchnik's NPI, 1811286024, was assigned on March 29, 2011. Dr. Muchnik holds Pennsylvania license MD457823.

Dr. Muchnik's primary practice is UPMC Williamsport, at 700 High Street, Williamsport, PA 17701 in Lycoming County. The practice phone is (570) 321-1000.

Dr. Muchnik's primary practice is UPMC Williamsport in Williamsport, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Muchnik is also affiliated with WellSpan Evangelical Community Hospital. The medical group on file is Susquehanna Health System. Dmand AI also links Dr. Muchnik to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muchnik practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Muchnik's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Muchnik's licenses on file in 2 states: Pennsylvania and New York.

CMS data shows 1,566 Medicare services from Dr. Muchnik across 8 procedure codes in 2024, for 439 Medicare patients. Medicare paid $145,861 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 439 Medicare patients who saw Dr. Muchnik in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muchnik's median patient age at 74, with 54% women.

In 2024, Dr. Muchnik wrote 1,742 Medicare Part D claims for 338 patients. 58% of them were for generic drugs. CMS names the drug for 1,508 of them, across 45 drugs with 11 or more claims each, at $10,174,661 in total drug cost. In 2023, CMS named 1,704 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Muchnik for performance year 2024, reported as part of a group. Dr. Muchnik accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 176 general payments to Dr. Muchnik from 33 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Mirati Therapeutics, Inc. paid the most, $30,688.